US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.530
  • +0.580+19.66%
Close Aug 9 16:00 ET
  • 3.600
  • +0.070+1.98%
Post 20:02 ET
370.03MMarket Cap-1096P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
RHA ® Collection of dermal fillers29.57M56.94%
DaxibotulinumtoxinA-lanm (DAXXIFY ®)22.15M42.65%
Collaboration revenue217K0.42%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States234.04M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%